Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Licenses RNAi Technology from Stanford University

NEW YORK, Oct. 16 (GenomeWeb News) - Benitec has obtained an exclusive license to use StanfordUniversity's Minicircle DNA technology, the company said last week.

 

Terms of the agreement allow Benitec to use the technology "for all RNAi therapeutic uses, with sub-licensing rights."

 

Minicircles was developed by Mark Kay, professor of pediatrics and genetics at Stanford, and a consultant to Benitec. It enables gene expression "up to 500 times greater" than with traditional plasmid DNA, according to Benitec.

 

"This license advances Benitec's ability to build effective RNAi therapeutics for our in-house disease programs and supports our pathfinder approach to the overall development of RNAi therapeutics," the company said in a statement. "We will ... continue to identify in-licensing opportunities for Benitec in delivery methods and clinical targets from other leading centers of innovation in both the United Statesand abroad."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.